Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate
There is limited clinical experience with the use of coagulation concentrates to reverse the effect of direct oral anticoagulants. We assess the achievement of effective clinical hemostasis with the use of 4-factor prothrombin complex concentrate (PCC) in patients on apixaban or rivaroxaban presenti...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Published: |
2019
|
| Online Access: | http://hdl.handle.net/10725/11360 https://doi.org/10.1007/s11739-018-1977-9 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://link.springer.com/article/10.1007/s11739-018-1977-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|